ストックスクリーナーアプリを入手
18.96
1.72%
0.32
アフターアワーズ：
19.25
0.29
+1.53%
前日終値:
$18.64
開ける：
$18.59
24時間の取引高:
17,344
Relative Volume:
0.65
時価総額：
$144.81M
収益：
-
当期純損益:
$-61.23M
株価収益率:
-1.4024
EPS:
-13.5194
ネットキャッシュフロー:
$22.49M
1週間 パフォーマンス:
+1.28%
1か月 パフォーマンス:
+9.98%
6か月 パフォーマンス:
+31.48%
1年 パフォーマンス:
+23.92%
1日の値動き範囲:
$18.40
$19.00
1週間の範囲:
$17.93
$19.11
52週間の値動き範囲:
$7.75
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
名前
Assembly Biosciences Inc
セクター
電話
(833) 409-4583
住所
TWO TOWER PLACE, SOUTH SAN FRANCISCO
ASMB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
18.96 | 138.16M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.55 | 119.76B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.93 | 59.14B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.81 | 41.40B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.92 | 32.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
279.16 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-25 | 開始されました | Guggenheim | Buy |
| 2024-09-20 | アップグレード | Jefferies | Hold → Buy |
| 2021-09-13 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-02 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | ダウングレード | Jefferies | Buy → Hold |
| 2020-10-19 | 開始されました | Truist | Buy |
| 2019-10-16 | 開始されました | Mizuho | Buy |
| 2018-11-19 | 開始されました | Leerink Partners | Outperform |
| 2018-10-08 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | 開始されました | Robert W. Baird | Outperform |
| 2018-04-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | 開始されました | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | 開始されました | Jefferies | Buy |
| 2017-05-30 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Assembly Biosciences Inc (ASMB) 最新ニュース
How NNAGR stock performs during market volatilityShort Term Profit Focus - Newser
What makes Assembly Biosciences Inc. stock price move sharplyReturn Optimized Trade Insights - Newser
What makes SKLZ stock price move sharplyMarket Trend Watch - Newser
When BATRK stock expected to show significant growthIs CHRS stock a good long term investment optionFree Stock Market Trend Analysis - Newser
What makes Trupanion Inc. stock price move sharplyStrong Return Daily Alerts - Newser
How CMCL stock performs during market volatilityFree Wealth-Building Investment Strategies - Newser
Why Assembly Biosciences Inc. stock attracts strong analyst attentionFree Consultation - Newser
How Assembly Biosciences Inc. stock performs during market volatilityHigh Potential Stock Ideas - Newser
Is It Worth Buying TRINITY(trinityswap)Free Professional Portfolio Management - Newser
(ASMB) On The My Stocks Page - news.stocktradersdaily.com
Assembly Biosciences, Inc. (ASMB) Announces Key Leadership and Plan Changes - Insider Monkey
Hepatitis D Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Assembly Biosciences Doses First Participant in Phase 1b Portion of Phase 1a/b Clinical Trial of Investigational Long-Acting Herpes Simplex Virus Helicase-Primase Inhibitor ABI-1179 - The Manila Times
Assembly Biosciences: A Breakthrough in Genital Herpes Treatment Could Trigger a Valuation Re-Rating - AInvest
Assembly Biosciences (ASMB) Reports Positive Phase 1b Results fo - GuruFocus
15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey
Assembly Bio reports positive results from HBV drug trial - Investing.com
Assembly Biosciences Reports Positive Phase 1b Trial Results - TipRanks
Assembly Biosciences, Inc. (NASDAQ:ASMB) stock most popular amongst individual investors who own 48%, while public companies hold 29% - Yahoo Finance
Where are the Opportunities in (ASMB) - news.stocktradersdaily.com
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 47.1% in May - Defense World
Live Biotherapeutic Products and Microbiome CDMO Market Size to Hit USD 1,496.69 Mn by 2034 - Precedence Research
Assembly Biosciences (NASDAQ:ASMB) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why - Defense World
Assembly Biosciences expands stock plans, appoints new CFO By Investing.com - Investing.com Nigeria
Assembly Biosciences expands stock plans, appoints new CFO - Investing.com
Assembly Biosciences Announces Stock Plan Amendments and Leadership Change - TipRanks
Assembly Biosciences IncJeanette M. Bjorkquist Appointed Principal Financial Officer On June 5- SEC Filing - MarketScreener
(ASMB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Assembly Biosciences, Inc. (NASDAQ:ASMB) Shares Sold by Northern Trust Corp - Defense World
When Will Assembly Biosciences, Inc. (NASDAQ:ASMB) Breakeven? - Yahoo Finance
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Up 99.2% in May - Defense World
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference - The Manila Times
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference | ASMB Stock News - GuruFocus
Assembly Bio Leadership Team Set for Key Presentation at Major Jefferies Healthcare Conference - Stock Titan
Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics - Business Wire
Assembly Biosciences's 15-minute chart shows RSI Overbought, KDJ Death Cross. - AInvest
Assembly’s NeosAI, Powered by Microsoft Azure AI Foundry, Sets New Benchmark for Legal Productivity—Backed by Real-World Results - GlobeNewswire Inc.
Mizuho Cuts Price Target on Assembly Biosciences to $29 From $36, Keeps Outperform Rating - marketscreener.com
ABI-4334 outperforms vebicorvir in HBV suppression - BioWorld MedTech
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Growth Investors: Industry Analysts Just Upgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue Forecasts By 33% - simplywall.st
Assembly Biosciences First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Zacks Research Cuts Earnings Estimates for Las Vegas Sands - Defense World
Assembly Biosciences: Q1 Earnings Snapshot - New Haven Register
Assembly Biosciences Reports First Quarter 2025 Financial Results and Recent Updates - The Manila Times
Assembly Biosciences Reports Q1 2025 Earnings - TipRanks
Assembly Biosciences Inc (ASMB) Q1 2025 Earnings: EPS of -$1.17 Beats Estimate, Revenue of $9.4M Exceeds Forecast - GuruFocus
Assembly Biosciences Updates on Clinical Progress and Financials, Anticipates Key Data in 2025 - Nasdaq
Assembly Biosciences Inc (ASMB) 財務データ
収益
当期純利益
現金流量
EPS
3.40%
2.49%
大文字化:
|
ボリューム (24 時間):